Israel tests US-backed missile shield as Iran nuclear deadline looms

Updated 01 April 2015

Israel tests US-backed missile shield as Iran nuclear deadline looms

JERUSALEM: A new Israeli air defense system being developed in partnership with the United States has passed advanced tests, the Israeli Defense Ministry said on Wednesday, putting it on course for possible deployment by next year.
Defense sources said tests for David’s Sling took place last week and on Tuesday, the last day before a deadline for international negotiations on Iran’s disputed nuclear program.
The terms of those talks have been vehemently opposed by Israel as insufficient and Prime Minister Benjamin Netanyahu said on Wednesday it was not too late for world powers to demand a “better deal.”
Apart from a potential nuclear showdown with Tehran, Israel sees threats from Syria and Lebanon’s Iranian-backed Hezbollah militia.
“In the Middle East there is no time to waste,” a senior Israeli defense official involved in the program told Reuters.
Known in Hebrew as Magic Wand, David’s Sling is being manufactured jointly by Israel’s state-owned Rafael Advanced Defense Systems Ltd. and US firm Raytheon Co..
Designed to shoot down rockets with ranges of between 100 km and 200 km (63 miles and 125 miles), aircraft or low-flying cruise missiles, it will fill the operational gap between Israel’s Iron Dome short-range rocket interceptor and the Arrow ballistic missile interceptor, both already active.
The latest successful tests will likely strengthen support among US lawmakers for Israel’s request for additional funds.
Israeli officials last month asked US lawmakers for $317 million in additional funding for David’s Sling and other Israeli missile defense programs, on top of $158 million in funding already requested by the Obama administration in its fiscal 2016 budget.
Last year, David’s Sling lost out on a Polish tender after Washington made clear to the Israelis that it preferred that a rival US system win.
The latest tests were conducted under unusually strict secrecy, and had been rescheduled at least once.
Planners had considered holding one of the tests on March 3, hours ahead of Prime Minister Benjamin Netanyahu’s controversial speech at the US Congress where he praised the Obama administration’s defense aid for Israel while rebuking its Iran negotiations.


Mideast faces opioid crisis as it rages through developing world

Updated 13 December 2019

Mideast faces opioid crisis as it rages through developing world

  • Mass abuse of the opioid tramadol spans continents, from India to Africa to the Middle East
  • Abuse is now so rampant some countries consumed by it are asking international authorities to intervene

KAPURTHALA: Reports rolled in with escalating urgency — pills seized by the truckload, pills swallowed by schoolchildren, pills in the pockets of dead terrorists.
These pills, the world has been told, are safer than the OxyContins, the Vicodins, the fentanyls that have wreaked so much devastation. But now they are the root of what the United Nations named “the other opioid crisis” — an epidemic featured in fewer headlines than the American one, as it rages through the most vulnerable countries on the planet.
Mass abuse of the opioid tramadol spans continents, from India to Africa to the Middle East, creating international havoc some experts blame on a loophole in narcotics regulation and a miscalculation of the drug’s danger. The man-made opioid was touted as able to relieve pain with little risk of abuse. Unlike other opioids, tramadol flowed freely around the world, unburdened by international controls that track most dangerous drugs.
But abuse is now so rampant some countries consumed by it are asking international authorities to intervene.

Grunenthal, the German company that originally made the drug, is campaigning for the status quo, arguing international regulations make narcotics difficult to get in countries with disorganized health systems, and adding tramadol to the list would deprive patients in pain access to any opioid at all.
“This is a huge public health dilemma,” said Dr. Gilles Forte, the secretary of the World Health Organization’s committee that recommends how drugs should be regulated. Tramadol is available in war zones and impoverished nations because it is unregulated. But it is widely abused for the same exact reason. “It’s a really very complicated balance to strike.”
Tramadol is not as deadly as other opioids and the crisis isn’t killing with the ferocity of America’s struggle withe the drugs. Still, individual governments from the US to Egypt to Ukraine have realized the drug’s dangers are not as limited as believed and worked to rein in the tramadol trade. The north Indian state of Punjab, the center of India’s opioid epidemic, was the latest to crack down. The pills were everywhere, as legitimate medication sold in pharmacies, but also illicit counterfeits hawked by street vendors.
This year, authorities seized hundreds of thousands of tablets, banned most pharmacy sales and shut down counterfeit pill factories, pushing the price from 35 cents for a 10-pack to $14. The government opened a network of treatment centers, fearing those who had become opioid addicted would resort to heroin out of desperation. Hordes of people rushed in to seek help in dealing with excruciating withdrawal.
For some, tramadol had become as essential as food.
“Like if you don’t eat, you start to feel hungry. Similar is the case with not taking it,” said auto shop welder Deepak Arora, a gaunt 30-year-old who took 15 tablets day, so much he had to steal from his family to pay for pills. “You are like a dead person.”
Jeffery Bawa, an officer with the United Nations Office on Drugs and Crime, realized what was happening in 2016.
Police began finding pills on terrorists, who traffic it to fund their networks and take it to bolster their capacity for violence, Bawa said.
Most of it was coming from India. The country’s sprawling pharmaceutical industry is fueled by cheap generics. Pill factories produce knock-offs and ship them in bulk around the world, in doses far exceeding medical limits.
In 2017, law enforcement reported that $75 million worth of tramadol from India was confiscated en route to the Islamic State terror group. Authorities intercepted 600,000 tablets headed for Boko Haram. Another 3 million were found in a pickup truck in Niger, in boxes disguised with UN logos. The agency warned that tramadol was playing “a direct role in the destabilization of the region.”
“We cannot let the situation get any further out of control,” that alert read.
Grunenthal has campaigned to keep tramadol unregulated. It funded surveys that found regulation would impede pain treatment, and paid consultants to travel to the WHO to make the case that it’s safer that other opioids.
Spokesman Stepan Kracala said regulation would not necessarily curtail illicit trade and could backfire: Some desperate pain patients turn to the black market if no legal options exist.
This has happened in India, which regulated tramadol in 2018. Regulators say exports overseas and abuse at home came down. But they acknowledge that the vastness of the pharmaceutical industry and the ingenuity of traffickers makes curtailing abuse and illegal exports all but impossible. Tramadol is still easy to find.
Jyoti Rani stood on her front steps and pointed to house after house in the small city of Kapurthala where she said tramadol is still sold in her neighborhood of narrow roads and open drains, where school-aged boys sit hunched over the street in the middle of a weekday.
Rani’s addiction began with heroin. When her 14-year-old son died, she fell into depression.
“I wanted to kill myself, but I ended up becoming an addict,” she cried. A doctor prescribed tramadol to help kick the habit — instead, she formed a new one.
Now she is among about 30,000 people in Punjab who go to government-run addiction clinics for daily treatment.
Countries’ efforts to control tramadol on their own often fail, according to the Center for Strategic and International Studies, particularly in places where addiction has taken hold.